Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 116

1.

Patients undergoing long-term treatment with antihypertensive eye drops responded positively with respect to their ocular surface disorder to oral supplementation with antioxidants and essential fatty acids.

Galbis-Estrada C, Pinazo-Durán MD, Cantú-Dibildox J, Marco-Ramírez C, Díaz-Llópis M, Benítez-del-Castillo J.

Clin Interv Aging. 2013;8:711-9. doi: 10.2147/CIA.S43191. Epub 2013 Jun 19.

PMID:
23818768
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Effects of a nutraceutical formulation based on the combination of antioxidants and ω-3 essential fatty acids in the expression of inflammation and immune response mediators in tears from patients with dry eye disorders.

Pinazo-Durán MD, Galbis-Estrada C, Pons-Vázquez S, Cantú-Dibildox J, Marco-Ramírez C, Benítez-del-Castillo J.

Clin Interv Aging. 2013;8:139-48. doi: 10.2147/CIA.S40640. Epub 2013 Feb 11.

PMID:
23430672
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Antioxidant and inflammatory cytokine in tears of patients with dry eye syndrome treated with preservative-free versus preserved eye drops.

Jee D, Park SH, Kim MS, Kim EC.

Invest Ophthalmol Vis Sci. 2014 Jul 3;55(8):5081-9. doi: 10.1167/iovs.14-14483.

PMID:
24994869
[PubMed - indexed for MEDLINE]
4.

Effects of oral sea buckthorn oil on tear film Fatty acids in individuals with dry eye.

Järvinen RL, Larmo PS, Setälä NL, Yang B, Engblom JR, Viitanen MH, Kallio HP.

Cornea. 2011 Sep;30(9):1013-9. doi: 10.1097/ICO.0b013e3182035ad9.

PMID:
21832964
[PubMed - indexed for MEDLINE]
5.

Glaucoma and dry eye.

Ali FS, Akpek EK.

Ophthalmology. 2009 Jun;116(6):1232. doi: 10.1016/j.ophtha.2008.12.034. No abstract available.

PMID:
19486808
[PubMed - indexed for MEDLINE]
6.

Antioxidants intake and dry eye syndrome: a crossover, placebo-controlled, randomized trial.

Drouault-Holowacz S, Bieuvelet S, Burckel A, Rigal D, Dubray C, Lichon JL, Bringer P, Pilon F, Chiambaretta F.

Eur J Ophthalmol. 2009 May-Jun;19(3):337-42.

PMID:
19396775
[PubMed - indexed for MEDLINE]
8.

Effect of artificial tears on automated visual field testing in patients with glaucoma and dry eye.

Kocabeyoglu S, Mocan MC, Bozkurt B, Irkec M.

Can J Ophthalmol. 2013 Apr;48(2):110-4. doi: 10.1016/j.jcjo.2012.11.001.

PMID:
23561604
[PubMed - indexed for MEDLINE]
9.

A multicentre, double-masked, randomized, controlled trial assessing the effect of oral supplementation of omega-3 and omega-6 fatty acids on a conjunctival inflammatory marker in dry eye patients.

Brignole-Baudouin F, Baudouin C, Aragona P, Rolando M, Labetoulle M, Pisella PJ, Barabino S, Siou-Mermet R, Creuzot-Garcher C.

Acta Ophthalmol. 2011 Nov;89(7):e591-7. doi: 10.1111/j.1755-3768.2011.02196.x. Epub 2011 Aug 11.

PMID:
21834921
[PubMed - indexed for MEDLINE]
10.

German register for glaucoma patients with dry eye. I. Basic outcome with respect to dry eye.

Erb C, Gast U, Schremmer D.

Graefes Arch Clin Exp Ophthalmol. 2008 Nov;246(11):1593-601. doi: 10.1007/s00417-008-0881-9. Epub 2008 Jul 22.

PMID:
18648841
[PubMed - indexed for MEDLINE]
11.

Immunomodulatory effect of the topical ophthalmic Janus kinase inhibitor tofacitinib (CP-690,550) in patients with dry eye disease.

Huang JF, Yafawi R, Zhang M, McDowell M, Rittenhouse KD, Sace F, Liew SH, Cooper SR, Pickering EH.

Ophthalmology. 2012 Jul;119(7):e43-50. doi: 10.1016/j.ophtha.2012.03.017. Epub 2012 May 18.

PMID:
22607938
[PubMed - indexed for MEDLINE]
12.
13.

[Efficacy assessment of Nutrilarm®, a per os omega-3 and omega-6 polyunsaturated essential fatty acid dietary formulation versus placebo in patients with bilateral treated moderate dry eye syndrome].

Creuzot-Garcher C, Baudouin C, Labetoulle M, Pisella PJ, Mouriaux F, Meddeb-Ouertani A, El Matri L, Khairallah M, Brignole-Baudouin F.

J Fr Ophtalmol. 2011 Sep;34(7):448-55. doi: 10.1016/j.jfo.2011.01.018. Epub 2011 Jun 22. French.

PMID:
21696849
[PubMed - indexed for MEDLINE]
Free Article
14.

Correlations between tear cytokines, chemokines, and soluble receptors and clinical severity of dry eye disease.

Na KS, Mok JW, Kim JY, Rho CR, Joo CK.

Invest Ophthalmol Vis Sci. 2012 Aug 13;53(9):5443-50. doi: 10.1167/iovs.11-9417.

PMID:
22789923
[PubMed - indexed for MEDLINE]
Free Article
15.

Safety and efficacy of cyclosporine 0.05% drops versus unpreserved artificial tears in dry-eye patients having laser in situ keratomileusis.

Salib GM, McDonald MB, Smolek M.

J Cataract Refract Surg. 2006 May;32(5):772-8.

PMID:
16765793
[PubMed - indexed for MEDLINE]
16.

Rebamipide (OPC-12759) in the treatment of dry eye: a randomized, double-masked, multicenter, placebo-controlled phase II study.

Kinoshita S, Awamura S, Oshiden K, Nakamichi N, Suzuki H, Yokoi N; Rebamipide Ophthalmic Suspension Phase II Study Group.

Ophthalmology. 2012 Dec;119(12):2471-8. doi: 10.1016/j.ophtha.2012.06.052. Epub 2012 Sep 23.

PMID:
23009892
[PubMed - indexed for MEDLINE]
17.

Effects of osmoprotection on symptoms, ocular surface damage, and tear film modifications caused by glaucoma therapy.

Monaco G, Cacioppo V, Consonni D, Troiano P.

Eur J Ophthalmol. 2011 May-Jun;21(3):243-50. doi: 10.5301/EJO.2010.5730.

PMID:
20872359
[PubMed - indexed for MEDLINE]
18.

Comparison of the long-term effects of various topical antiglaucoma medications on meibomian glands.

Arita R, Itoh K, Maeda S, Maeda K, Furuta A, Tomidokoro A, Aihara M, Amano S.

Cornea. 2012 Nov;31(11):1229-34. doi: 10.1097/ICO.0b013e31823f8e7d.

PMID:
22406943
[PubMed - indexed for MEDLINE]
19.
20.

Oral sea buckthorn oil attenuates tear film osmolarity and symptoms in individuals with dry eye.

Larmo PS, Järvinen RL, Setälä NL, Yang B, Viitanen MH, Engblom JR, Tahvonen RL, Kallio HP.

J Nutr. 2010 Aug;140(8):1462-8. doi: 10.3945/jn.109.118901. Epub 2010 Jun 16.

PMID:
20554904
[PubMed - indexed for MEDLINE]
Free Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk